MZP — Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus Class II

FDA Device Classification

FDA product code MZP covers "Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus", a Class II medical device regulated under 21 CFR 866.3170. Submissions are reviewed by the Microbiology panel. At least 4 recent 510(k) clearances have been granted under this product code.